BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 22956701)

  • 21. A retrospective electronic chart review of blood pressure changes in elderly patients treated with amlodipine or an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker.
    Dollar A; Brown C; Putnam D; McLaughlin T; Okamoto L; Arocho R
    Clin Ther; 2002 Jun; 24(6):930-41. PubMed ID: 12117083
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Angiotensin-Converting Inhibitors and Angiotensin II Receptor Blockers and Longitudinal Change in Percent Emphysema on Computed Tomography. The Multi-Ethnic Study of Atherosclerosis Lung Study.
    Parikh MA; Aaron CP; Hoffman EA; Schwartz JE; Madrigano J; Austin JHM; Kalhan R; Lovasi G; Watson K; Stukovsky KH; Barr RG
    Ann Am Thorac Soc; 2017 May; 14(5):649-658. PubMed ID: 28207279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Renin-Angiotensin System Blockade Discontinuation and All-Cause Mortality Among Persons With Low Estimated Glomerular Filtration Rate.
    Qiao Y; Shin JI; Chen TK; Inker LA; Coresh J; Alexander GC; Jackson JW; Chang AR; Grams ME
    JAMA Intern Med; 2020 May; 180(5):718-726. PubMed ID: 32150237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Monitoring and adverse events in relation to ACE inhibitor/angiotensin receptor blocker initiation in people with diabetes in general practice: a population database study.
    Mathieson L; Severn A; Guthrie B
    Scott Med J; 2013 May; 58(2):69-76. PubMed ID: 23728750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Continuation of Angiotensin-Converting Enzyme Inhibitors on the Day of Surgery Is Not Associated With Increased Risk of Hypotension Upon Induction of General Anesthesia in Elective Noncardiac Surgeries.
    Yoon U; Setren A; Chen A; Nguyen T; Torjman M; Kennedy T
    J Cardiothorac Vasc Anesth; 2021 Feb; 35(2):508-513. PubMed ID: 32029371
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An angiotensin-converting enzyme (ACE) polymorphism may mitigate the effects of angiotensin-pathway medications on posttraumatic stress symptoms.
    Nylocks KM; Michopoulos V; Rothbaum AO; Almli L; Gillespie CF; Wingo A; Schwartz AC; Habib L; Gamwell KL; Marvar PJ; Bradley B; Ressler KJ
    Am J Med Genet B Neuropsychiatr Genet; 2015 Jun; 168B(4):307-15. PubMed ID: 25921615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescribing patterns of evidence-based heart failure pharmacotherapy and outcomes in the ASIAN-HF registry: a cohort study.
    Teng TK; Tromp J; Tay WT; Anand I; Ouwerkerk W; Chopra V; Wander GS; Yap JJ; MacDonald MR; Xu CF; Chia YM; Shimizu W; ; Richards AM; Voors A; Lam CS
    Lancet Glob Health; 2018 Sep; 6(9):e1008-e1018. PubMed ID: 30103979
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Unspecified intestinal malabsorption in patients treated with angiotensin-converting enzyme inhibitors or angiotensin receptor blockers: a retrospective analysis in primary care settings.
    De Bortoli N; Ripellino C; Cataldo N; Marchi S
    Expert Opin Drug Saf; 2017 Nov; 16(11):1221-1225. PubMed ID: 28871813
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Length of initial prescription at hospital discharge and long-term medication adherence for elderly patients with coronary artery disease: a population-level study.
    Ivers NM; Schwalm JD; Jackevicius CA; Guo H; Tu JV; Natarajan M
    Can J Cardiol; 2013 Nov; 29(11):1408-14. PubMed ID: 23816280
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility and impact of implementing a private care system's diabetes quality improvement intervention in the safety net: a cluster-randomized trial.
    Gold R; Nelson C; Cowburn S; Bunce A; Hollombe C; Davis J; Muench J; Hill C; Mital M; Puro J; Perrin N; Nichols G; Turner A; Mercer M; Jaworski V; Howard C; Abiles E; Shah A; Dudl J; Chan W; DeVoe J
    Implement Sci; 2015 Jun; 10():83. PubMed ID: 26059264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. How Admission to a Vascular Surgery Department Improves Medical Treatment in Patients with Lower Extremity Peripheral Arterial Disease.
    Thiney M; Della Schiava N; Feugier P; Lermusiaux P; Ninet J; Millon A; Long A
    Ann Vasc Surg; 2017 Apr; 40():85-93. PubMed ID: 27908822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utilization of Evidence-Based Secondary Prevention Medications at the Time of Discharge in Patients with Acute Coronary Syndrome (ACS) in Qatar.
    El-Hajj MS; Saad A; Al-Suwaidi J; Al-Marridi WZ; Elkhalifa DH; Mohamed AA; Mahfoud ZR
    Curr Vasc Pharmacol; 2016; 14(4):394-403. PubMed ID: 26916397
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular and Renal Outcomes of Renin-Angiotensin System Blockade in Adult Patients with Diabetes Mellitus: A Systematic Review with Network Meta-Analyses.
    Catalá-López F; Macías Saint-Gerons D; González-Bermejo D; Rosano GM; Davis BR; Ridao M; Zaragoza A; Montero-Corominas D; Tobías A; de la Fuente-Honrubia C; Tabarés-Seisdedos R; Hutton B
    PLoS Med; 2016 Mar; 13(3):e1001971. PubMed ID: 26954482
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Secondary Prevention Medication on the Prognosis in Patients With Myocardial Infarction With Nonobstructive Coronary Artery Disease.
    Abdu FA; Liu L; Mohammed AQ; Xu B; Yin G; Xu S; Xu Y; Che W
    J Cardiovasc Pharmacol; 2020 Dec; 76(6):678-683. PubMed ID: 33284169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ranolazine, ACE Inhibitors, and Angiotensin Receptor Blockers.
    Marciniak TA; Serebruany V
    Am J Med; 2019 Dec; 132(12):e844-e845. PubMed ID: 30871921
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adherence to statins, beta-blockers and angiotensin-converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study.
    Blackburn DF; Dobson RT; Blackburn JL; Wilson TW; Stang MR; Semchuk WM
    Can J Cardiol; 2005 May; 21(6):485-8. PubMed ID: 15917876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation.
    Thacker EL; Jensen PN; Psaty BM; McKnight B; Longstreth WT; Dublin S; Newton KM; Smith NL; Siscovick DS; Heckbert SR
    Ann Pharmacother; 2015 Apr; 49(4):378-86. PubMed ID: 25628466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effectiveness of angiotensin-converting-enzyme inhibitors and angiotensin II receptor blockers in patients with type 2 diabetes and retinopathy.
    Shih CJ; Chen HT; Kuo SC; Li SY; Lai PH; Chen SC; Ou SM; Chen YT
    CMAJ; 2016 May; 188(8):E148-E157. PubMed ID: 27001739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of angioedema associated with the use of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
    Malde B; Regalado J; Greenberger PA
    Ann Allergy Asthma Immunol; 2007 Jan; 98(1):57-63. PubMed ID: 17225721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prescription drug benefits and use of guideline recommended medications by elderly Medicare beneficiaries with diabetes mellitus.
    Tjia J; Briesacher BA
    J Am Geriatr Soc; 2008 Oct; 56(10):1879-86. PubMed ID: 18771456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.